GlaxoSmithKline saves 120 jobs by reversing plan to close plant

Global pharmaceutical and healthcare company GlaxoSmithKline (GSK) has reversed a decision to shut a plant run by one of its subsidiaries, saving over 100 jobs.

The Stiefel facility in Co Sligo will remain open with an investment of €10m and initially retaining 120 of the 180 staff. It had been due to close next year.

GSK, which bought the business in 2009, announced that the plant will become a dedicated skin healthcare supply and bottling site and it aims to take on 50 additional staff in 2014.